Trials / Terminated
TerminatedNCT01856439
Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
A Multicentre, Open-label Study to Determine the Long Term Safety, Tolerability and Efficacy of ProSavin in Patients With Bilateral, Idiopathic Parkinson's Disease.
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Axovant Sciences Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is designed to assess the long term tolerability of ProSavin and whether it is safe and efficacious in patients administered ProSavin from the PS1/001/07 study .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ProSavin | Long term follow up of patients who received ProSavin in a previous study |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2021-11-01
- Completion
- 2022-04-01
- First posted
- 2013-05-17
- Last updated
- 2022-05-03
Locations
2 sites across 2 countries: France, United Kingdom
Source: ClinicalTrials.gov record NCT01856439. Inclusion in this directory is not an endorsement.